| abstract |
The present invention relates to heme-containing polypeptide variants having a reduced or eliminated activity, and polynucleotides encoding the variants. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptide variants, such as the use of the polypeptide variants in food or feed. |